News

FDA pipeline preview

Innovative state experiments propel health reform forward

State experiences vary, and officials could assume a larger role by 2016

ACOs, bundled payment, shared savings require new capabilities and new culture

RADV audits can help by confirming that a plan has actually captured the most accurate and complete diagnostic information about its members to deliver the right care to those members based on their needs

Aetna examines technology solutions to advance evidence-based care

Study reveals mixed results in expanded Medicaid plan

The 2012 drug trend declined 3.5% but members are paying three to five times more in overall healthcare costs

Ohio's Republican governor might have to sell the statehouse on the idea

A national program aims to accelerate treatment and diagnosis

Massachusetts adds cost containment goals, something PPACA lacks

Plan's data show 1.2% of screenings resulted in cancer diagnosis

Payer and provider affiliation deals vary and bring up new questions

Transparency still has a long way to go

Employers look for loopholes but most will keep coverage plans in tact

Eventually, states could expand their roles in the exchange operations

Decolonization of all intensive care unit (ICU) patients with antimicrobial soap and ointment significantly reduces all bloodstream infections, including methicillin-resistant Staphylococcus aureus (MRSA), according to a study published in the New England Journal of Medicine.

Testing patients with just 3 risk factors upon hospital admission has potential to identify nearly 3 out of 4 asymptomatic carriers of C difficile, according to a new study published in the May issue of the American Journal of Infection Control.

Men using long-term, high dose prescription opioids for back pain were about 50% more likely to be using medications for erectile dysfunction than men with back pain who were not using opioids, according to a study published in a recent issue of Spine.

After its recent review, the US Preventive Services Task Force (USPSTF) could not recommend supplementation with vitamin D and calcium for the primary prevention of fractures in healthy adults.

Outpatient hemodialysis facilities realized a 32% decrease in overall bloodstream infections and a 54% decrease in vascular access-related bloodstream infections after Centers for Disease Control and Prevention (CDC) guidelines were used, according to a new study.

Four ways to deliver a value case that resonates with stakeholders.

Soon after FDA expressed concerns over the higher dosages and safety profile, including daytime drowsiness, of the proposed sleep agent known as suvorexant (Merck), the Agency’s Peripheral and Central Nervous System Drugs Advisory Committee voted 13-3, with 1 abstention, in favor of the safety of 2 proposed starting doses of suvorexant - 15 mg in patients over the age of 65 and 20 mg in patients under the age of 65.

Sandoz is conducting a voluntary nationwide recall at the U.S. hospital/user level of 2 lots of its injectable methotrexate sodium, USP, 25 mg/mL, 40 mL vials, as a result of the discovery of particulate matter during routine quality examination of vials included among the manufacturer’s retention samples.

Due to a recurring error that sometimes prompts FreeStyle InsuLinx Blood Glucose Meters to display false test readings, Abbott Diabetes Care has voluntarily recalled the product.

An examination of people’s behaviors as they relate to drug use in the 20th century has shown that people will expend a large amount of energy to acquire any agent that has the ability to alter their minds, bodies, or behaviors in order to achieve a euphoric effect.

The proposal of the investigational sleep agent called suvorexant (Merck), is believed to target sleep disturbances and insomnia through a different mechanism compared to the agents that are currently on the market, but FDA has concerns over the higher dosages of the drug and its safety profile.